22,208
edits
Changes
Jump to navigation
Jump to search
m
remove <coauthors> parameter
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews
| last= | first= | coauthors= | url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | date=November 2011 | publisher=FDA | quote= | accessdate=2011-12-20
}}</ref>